PORTFOLIO NEWS NGM Reports Business Highlights and Third Quarter 2019 Financial Results November 9, 2019 Read More » Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results November 6, 2019 Read More » Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy November 5, 2019 Read More » Arcus Biosciences Announces Third Quarter 2019 Financial Results and Recent Corporate Updates November 5, 2019 Read More » A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics November 5, 2019 Read More » RAPT Therapeutics Announces Pricing of Initial Public Offering October 31, 2019 Read More » ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference October 28, 2019 Read More » RAPT Therapeutics Announces Initiation of First-In-Human Phase 1 Study of RPT193 October 23, 2019 Read More » Plexium Launches with $28 Million in Series A Financing October 17, 2019 Read More » NGM Bio Announces Positive Interim Results from Ongoing 24-Week Phase 2 Study Evaluating Aldafermin (NGM282) in Patients with NASH October 7, 2019 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
NGM Reports Business Highlights and Third Quarter 2019 Financial Results November 9, 2019 Read More »
Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results November 6, 2019 Read More »
Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE Platform and Contained Within its SLATE Immunotherapy November 5, 2019 Read More »
Arcus Biosciences Announces Third Quarter 2019 Financial Results and Recent Corporate Updates November 5, 2019 Read More »
A2 Biotherapeutics Emerges From Stealth Mode With $57M Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics November 5, 2019 Read More »
ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference October 28, 2019 Read More »
RAPT Therapeutics Announces Initiation of First-In-Human Phase 1 Study of RPT193 October 23, 2019 Read More »
NGM Bio Announces Positive Interim Results from Ongoing 24-Week Phase 2 Study Evaluating Aldafermin (NGM282) in Patients with NASH October 7, 2019 Read More »
